CLEC10A and cancer: HERV expression, including that of HML.2, was noted in malignant tumors such as human breast cancer, ovarian cancer, germinal tumors, melanomas [12,13,14,15,16,17] and in association with multiple sclerosis, and other autoimmune and neurological disorders [18,19,20,21,22].